Lv4
582 积分 2023-08-20 加入
Management and outcomes of anastomotic leakage after McKeown esophagectomy: A retrospective analysis of 749 consecutive patients with esophageal cancer
1天前
待确认
A pathologic classification approach in esophageal squamous cell carcinoma following neoadjuvant immunochemotherapy: Distinguishing postoperative outcomes and exploring the potential benefit of adjuvant therapy
4个月前
已完结
New guidelines to evaluate the response to treatment in solid tumors
5个月前
已完结
Safety and Efficacy of Pembrolizumab Combined With Paclitaxel and Cisplatin as a Neoadjuvant Treatment for Locally Advanced (Stage III) Esophagealsquamous Cell Carcinoma (Keystone-001) (NCT04389177): Interim Results of a Prospective, Single-Arm, Single-Center, Phase II Trial
6个月前
已关闭
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
6个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment [12] of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study[J]
6个月前
已关闭
Oesophageal cancer
6个月前
已完结
TGFbeta signaling in growth control, cancer, and heritable disorders
8个月前
已完结
Targeting TGF-β Signaling in Cancer
8个月前
已完结
Senescence as a therapeutic target in cancer and age-related diseases
8个月前
已完结
皖公网安备34019202002308
